Biotechnology Reagents & Kits Market Analysis Report By Kit Type, By Technology, By Tested Parameters, By Micro-Organisms, By Purpose, By End Use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global biotechnology reagents & kits market was appreciated by USD 337.28 billion in 2020. It is projected to witness 16.5% CAGR from 2021 to 2028.

Drivers

Increasing demand for synthetic biology, technical progressions in the biotechnology subject, growing use of molecular biology, and rising R&D spending by the biotechnology companies are the most important factors responsible for the enlargement of the market for biotechnology reagents & kits.

The growth of several analytical tests, used for Covid-19, has additionally propelled the expansion of the market. The fresh research has recommended the application of a flow cytometry sourced technique for Covid-19 investigation.

Besides, the researchers have utilized the method to search the kind of T cells, engaged in Covid-19 resistant reaction. This has caused the greater demand for flow cytometry reagents & kits, by this means increasing the expansion of the market.

By the latest progressions in the molecular biology field, a number of approaches and engineering tools were build up to deal with increasing market demand. Escalating research source in molecular biology has propelled the use of biotechnology reagents & kits, during the previous few years.

Purpose Insight

The on-site purposes section held the main, over 55.0% revenue share of the biotechnology reagents & kits market, in 2020. Mainly, the increasing deployment of Point-of-Care (POC) testing has pushed the expansion of the section.
Micro Organisms Insight

The virus section held the foremost, above 31.0% revenue share of the market, in 2020. It is directly tracked by the bacteria division. The supremacy of the section can be credited to the rising function of viruses in vaccinology plus gene treatment. Rising R&D actions, on the way to support the utilization of recombinant viral vectors in vaccine improvement, additionally, impels the development of the section.

The application of curative bacteria has transformed cancer administration, by means of facilitating to focus on specific restrictions, linked with the usual cancer treatment such as immunotherapy, surgery, chemotherapy, and radiotherapy. Only, the bacteria possess the ability to perform like anticancer mediator. These features are expected to increase the enlargement of the section, during the forecast period.

Tested Parameters Insight

The RNA section held the principal, more than 29.0% revenue share of the biotechnology reagents & kits market, because of the rising research on transcriptomics. The research activities on extracellular RNA, meant for the scientific analysis, have augmented during the previous five years.

The universities as well as companies are incoming into the domain, intended for the improvement of RNA sourced healing, by means of the advantage of transcriptomics technologies.

Technology Insight

Cell culture technology section held, above 24.0% revenue share and led the market, in 2020. It is tracked by Polymerase Chain Reaction (PCR) technology. Rising insist for cell culture reagents by means of the research society is steering the enlargement of the section. The complete range of the cell culture media as well as reagents possessed by the companies has increased the expansion of the market.

At the present, Next-Generation Sequencing (NGS) is measured as dependable, in addition to influential means used for the description of cell lines, aimed at the manufacture of recombinant proteins, vaccines and gene treatment. Therefore, by means of the progression in sequencing method, the market for sequencing reagents is expected to observe major enlargement, during the forecast period.

Kit Type Insight

The detection kits section held, above 22.0% revenue share and led the biotechnology reagents & kits market, in 2020. This can be credited to the extensive use of detection kits at a variety of end-use locations, for example agriculture, industrialized processing, food and industrial processing. During the previous few months, the manufacture of the detection kits has augmented, because of the rising necessity to restrict the spread of Covid-19 disease.

Growing insist for the molecular diagnostics is a most important thing adding to the escalation of the amplification kits. Healthcare, in addition to biotechnology companies, have augmented the manufacture of RT-PCR-sourced testing kits because of the global fast growth in the figure of Covid-19 cases.

End Use Insight

The healthcare division held the major, above 50.0% revenue shares and led the market, in 2020. As a result of the constant clinical trials along with research & development actions, intended for the scientific diagnostics, the division will maintain the foremost place, all through the forecast years.

The growing infiltration of biotechnology tools, to generate character of organisms together with microorganisms, animal, and plant, which is used for color, yield, and size, is pushing the expansion of food & agriculture section.

Regional Insight

In 2020, North America held above 37.0% revenue share and led the global biotechnology reagents & kits market. The presentation of some new-fangled products by promising start-ups, together with the attendance of major companies, which are aggressively developing technically superior new products, are the factors that has mainly added to the domination of the region.

The U.S. centered businesses and companies are incessantly engaged in premium research on life sciences, thus have an effect on the auxiliary markets. A variety of planned projects by the major companies, to retain existence in the local market as well as increase the share, augments the contest.

Asia Pacific is projected to be the maximum increasing regional market, throughout the forecast period. Rising research actions, intended for the improvement of effectual therapeutics, advancing infrastructure for diagnostics & therapeutics together with the increasing disposable earnings, are the various factors, powering the expansion of the local market.

Companies

The market for biotechnology reagents & kits is likely to observe remarkable enlargement, during the near future. An increase in the figure of technical partnerships amid working units together with their increasing product range has stepped up the rivalry in the market. The development of new equipment/product, taken on by the major companies, optimistically influences the enlargement of the market, along with augments their competitiveness, within the market.

The biotechnology companies are aggressively taking action against the eruption of the Covid-19 pandemic. Additionally, this has produced openings for the companies, trying hard to achieve a greater market share, via capitalizing on untouched opportunities.

Some of the companies for biotechnology reagents & kits market are:

    • LGC Ltd.
    • Promega Corp.
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Thermo Fisher Scientific
    • Toyobo Co. Ltd.
    • Takara Bio, Inc.
    • Merck KGaA
    • Bio-Rad Laboratories
    • Illumina, Inc.
    • QIAGEN

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Million Insights has segmented the global biotechnology reagents & kits market report on the basis of kit type, technology, tested parameters, micro-organisms, purpose, end use, and region:

• Kit Type Outlook (Revenue, USD Billion, 2017 - 2028)
    • Purification Kits
    • Amplification Kits
    • Detection Kits
    • Isolation Kits
    • Others

• Technology Outlook (Revenue, USD Billion, 2017 - 2028)
    • LAMP Technology
    • PCR
    • Cell Culture
    • Sequencing
    • Chromatography
    • Electrophoresis
    • Flow Cytometry
    • Other Technologies

• Tested Parameters Outlook (Revenue, USD Billion, 2017 - 2028)
    • DNA
    • RNA
    • Enzymes
    • Proteins
    • Others

• Micro-Organisms Outlook (Revenue, USD Billion, 2017 - 2028)
    • Bacteria
    • Virus
    • Fungi
    • Parasites

• Purpose Outlook (Revenue, USD Billion, 2017 - 2028)
    • On-Site
    • Laboratory

• End-use Outlook (Revenue, USD Billion, 2017 - 2028)
    • Healthcare
    • Food & Agriculture
    • Natural Resources & Environment
    • Industrial Processing
    • Others

• Regional Outlook (Revenue, USD Billion, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • Italy
        • France
        • Spain
    • Asia Pacific
        • China
        • India
        • Australia
        • Japan
    • Latin America
        • Brazil
        • Mexico
    • Middle East Africa (MEA)
        • South Africa
        • Saudi Arabia